Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

WHO says COVID-19 pandemic is 'one big wave', not seasonal
WHO says COVID-19 pandemic is 'one big wave', not seasonal
GENEVA (Reuters) - A World Health Organization official on Tuesday described the COVID-19 pandemic as “one big wave” and warned against complacency in the northern hemisphere summer since ...
Antiviral method against herpes paves the way for combatting incurable viral infections
Antiviral method against herpes paves the way for combatting incurable viral infections
Researchers at Lund University in Sweden have discovered a new method to treat human herpes viruses.
Moderna stock sinks as patent case spurs concern for COVID-19 vaccine
Moderna stock sinks as patent case spurs concern for COVID-19 vaccine
A patent court has sided with Arbutus Biopharma in its dispute with Moderna, raising concerns that the intellectual property dispute could stymie COVID-19 vaccine development.
Gilead's Kite bags second CAR-T okay with Tecartus nod in mantle cell lymphoma
Gilead's Kite bags second CAR-T okay with Tecartus nod in mantle cell lymphoma
Yescarta may be falling short of Gilead Sciences' hopes from back when the company shelled out $11.
Lonza sees no delays for COVID-19 vaccine project, citing Trump backing
Lonza sees no delays for COVID-19 vaccine project, citing Trump backing
ZURICH (Reuters) - Swiss drugmaker Lonza (LONN.
Panexcell Clinical Laboratories: suspension of medicines over flawed studies
Panexcell Clinical Laboratories: suspension of medicines over flawed studies
EMA’s human medicines committee (CHMP) has recommended the suspension of the marketing authorisations of generic medicines tested by Panexcell Clinical Laboratories Priv.
EU eyes COVID-19 vaccines at less than $40, shuns WHO-led alliance
EU eyes COVID-19 vaccines at less than $40, shuns WHO-led alliance
BRUSSELS, July 24 - The European Union is not interested in buying potential COVID-19 vaccines through an initiative co-led by the World Health Organisation as it deems it slow and high-cost, two EU s...
Indivior to resolve U.S. opioid treatment marketing claims for $600 million
Indivior to resolve U.S. opioid treatment marketing claims for $600 million
July 24 (Reuters) - Indivior Plc INDV.
Sixth Pharmaceutical Company Charged In Ongoing Criminal Antitrust Investigation
Sixth Pharmaceutical Company Charged In Ongoing Criminal Antitrust Investigation
Taro Pharmaceuticals U.
AZ' COPD therapy wins US approval
AZ' COPD therapy wins US approval
AstraZeneca has bagged a green light in the US for Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) as maintenance treatment for patients with chronic obstructive pulmonary d...
WHO says U.S., Brazil and India can 'deal with' pandemic
WHO says U.S., Brazil and India can 'deal with' pandemic
GENEVA (Reuters) - The World Health Organization said on Thursday that the United States, Brazil and India, which are all suffering fast rises in coronavirus cases, can still get on top of the...
Samsung Biologics Seeks to Add Fourth Plant
Samsung Biologics Seeks to Add Fourth Plant
As capacity at its 3 existing plants begins to run out, Samsung Biologics will add a fourth plant to its Incheon, Republic of Korea, site.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand